A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

In this comprehensive online program experts discuss how to select optimal therapies for patients with B-cell lymphomas. Get up to date with expert commentaries an on-demand webcast and slides from a dynamic CCO symposium at ASH 2021 downloadable resources on 10 key agent classes and an audio podcast.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Atara Biotherapeutics

Bayer Healthcare Pharma

BeiGene, Ltd.

Epizyme

Genentech, a member of the Roche Group

Genmab US, Inc.

Incyte Corporation

Karyopharm Therapeutics

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc